SCHEMBL4902852

SCHEMBL4902852

CC(C)Oc1ccc(I)nc1Nc1ccccn1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 3/20 0.53
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
CCNA2 P20248 1/20 0.40
CDK2 P24941 1/20 0.40
CCNA1 P78396 1/20 0.40
CDK5 Q00535 1/20 0.40
DYRK1A Q13627 1/20 0.40
CDK5R1 Q15078 1/20 0.40
MAPK10 P53779 1/20 0.40
GFER P55789 1/20 0.40
MAT2A P31153 1/20 0.38
PTK2 Q05397 1/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
POLB P06746 1/20 0.36
ULK1 O75385 2/20 0.36
TRPM8 Q7Z2W7 1/20 0.36
IGF1R P08069 1/20 0.36
ALDH1A1 P00352 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4899470 0.84 GRM5 (0.50) GRM5MEN1KMT2AMAPK10GFER
Hydrochloric Acid SCHEMBL4900785 0.83 GRM5 (0.50) GRM5MEN1KMT2ACCNA2CDK2
SCHEMBL4904931 0.78 GRM5 (0.50) GRM5MEN1KMT2AMAPK10GFER
SCHEMBL4895056 0.78 GRM5 (0.56) GRM5MEN1KMT2AMAPK10GFER
SCHEMBL4897041 0.75 KMT2A (0.47) GRM5MEN1KMT2ANPC1RAB9A
SCHEMBL7918433 0.73 GRM5 (0.45) GRM5MEN1KMT2ACCNA2CDK2
SCHEMBL5259986 0.73 KMT2A (0.48) GRM5MEN1KMT2AMAPK10GFER
SCHEMBL5259981 0.73 KMT2A (0.47) GRM5MEN1KMT2AMAPK10GFER
SCHEMBL1633247 0.69 GRM5 (0.46) GRM5MEN1KMT2ACCNA2CDK2
SCHEMBL4901928 0.68 MEN1 (0.48) GRM5MEN1KMT2AGFERPTK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080108600-A1 Polycyclic Pyridines as Potassium Ion Channel Modulators ICAGEN, INC. (US) 2008-05-08 US disclosed
CN-1980923-A Polycyclic pyridines as potassium ion channel modulators ICAGEN INC (US) 2007-06-13 CN disclosed
EP-1737852-A2 POLYCYCLIC PYRIDINES AS POTASSIUM ION CHANNEL MODULATORS Icagen, Inc. (US) 2007-01-03 EP disclosed
WO-2005100349-A2 POLYCYCLIC PYRIDINES AS POTASSIUM ION CHANNEL MODULATORS ICAGEN, INC. (US) 2005-10-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080108600-A1 Polycyclic Pyridines as Potassium Ion Channel Modulators KCNJ2, KCNH2, KCNQ1 GRM5 392/4885MEN1 2428/4885KMT2A 563/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.